N-3 Polyunsaturated Fatty Acids Modulate the Expression of Functionally Associated Molecules on Human Monocytes and Inhibit Antigen-presentation in Vitro
Overview
Authors
Affiliations
N-3 polyunsaturated fatty acid (PUFA)-rich diets are associated with suppression of cell-mediated immune responses, but the mechanisms are unclear. Specific immune responses are initiated by antigen-presenting cells (APC). We have previously shown in vitro that the n-3 PUFA, eicosapentaenoic acid (EPA), inhibits the expression of HLA-DR, an MHC class II molecule required for normal APC function on human blood monocytes. In contrast, docosahexaenoic acid (DHA) enhanced the expression of this molecule on unstimulated monocytes, but both n-3 PUFA suppressed its expression on interferon-gamma (IFN-gamma)-activated monocytes. In the present study we show that when EPA and DHA were combined at the same ratio as is commonly found in fish oil supplement capsules (3:2) there was no significant effect in vitro on the expression of HLA-DR on unstimulated monocytes, but the expression on IFN-gamma-activated monocytes remained significantly inhibited. In the same in vitro system a significant reduction in the ability of IFN-gamma-activated monocytes to present tetanus toxoid antigen to autologous lymphocytes was observed following culture with the combined n-3 PUFA. These findings support previous animal studies which suggest that n-3 PUFA can inhibit the antigen-presenting function of mononuclear phagocytes.
Xin G, Yang J, Li R, Gao Q, Li R, Wang J Bioengineered. 2022; 13(3):6173-6187.
PMID: 35200081 PMC: 8974180. DOI: 10.1080/21655979.2022.2043018.
The Effect of Omega-3 Fatty Acids on Rheumatoid Arthritis.
Kostoglou-Athanassiou I, Athanassiou L, Athanassiou P Mediterr J Rheumatol. 2020; 31(2):190-194.
PMID: 32676556 PMC: 7362115. DOI: 10.31138/mjr.31.2.190.
Therapeutic Potential of ω-3 Polyunsaturated Fatty Acids in Human Autoimmune Diseases.
Li X, Bi X, Wang S, Zhang Z, Li F, Zhao A Front Immunol. 2019; 10:2241.
PMID: 31611873 PMC: 6776881. DOI: 10.3389/fimmu.2019.02241.
Immune regulation and anti-cancer activity by lipid inflammatory mediators.
Khadge S, Sharp J, McGuire T, Thiele G, Black P, DiRusso C Int Immunopharmacol. 2018; 65:580-592.
PMID: 30447537 PMC: 6322683. DOI: 10.1016/j.intimp.2018.10.026.
Lipid Inflammatory Mediators in Cancer Progression and Therapy.
Khadge S, Sharp J, McGuire T, Thiele G, Talmadge J Adv Exp Med Biol. 2017; 1036:145-156.
PMID: 29275470 DOI: 10.1007/978-3-319-67577-0_10.